LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 4 of total 4

Search options

  1. Article: When Rules Are Not Enough: Developing Principles to Guide Ethical Conduct.

    Kelly, Elizabeth M / Greeny, Kaitlin / Rosenberg, Nancy / Schwartz, Ilene

    Behavior analysis in practice

    2020  Volume 14, Issue 2, Page(s) 491–498

    Abstract: Currently, certified behavior analysts are required to adhere to the ethical rules established by the Behavior Analyst Certification Board® (BACB®) known as ... ...

    Abstract Currently, certified behavior analysts are required to adhere to the ethical rules established by the Behavior Analyst Certification Board® (BACB®) known as the
    Language English
    Publishing date 2020-10-23
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2583900-7
    ISSN 2196-8934 ; 1998-1929
    ISSN (online) 2196-8934
    ISSN 1998-1929
    DOI 10.1007/s40617-020-00515-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    Full text online

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  2. Article ; Online: A Review of OB/GYN, Internal Medicine, Family Medicine, and Pediatrics Residency Program Websites for Diversity, Equity, and Inclusion Elements.

    Mallicoat, Benjamin C / Herstine, Blake A S / Kelly, Elizabeth M / Koechley, Hannah E / DeSouza, Julie A / Anas, Sydney A / Maxwell, Rose A / Reisinger-Kindle, Keith M

    Journal of graduate medical education

    2023  Volume 15, Issue 3, Page(s) 316–321

    Abstract: Background: Residency program websites have become a central source of information for applicants due to a shift toward virtual interviewing. Applicants, particularly those from diverse backgrounds, place strong value on programs that present ... ...

    Abstract Background: Residency program websites have become a central source of information for applicants due to a shift toward virtual interviewing. Applicants, particularly those from diverse backgrounds, place strong value on programs that present commitments to diversity, equity, and inclusion (DEI). The DEI content of residency program websites for primary care specialties has been largely unexplored.
    Objective: The objective of this study is to review, in an exploratory manner, family medicine, internal medicine, obstetrics and gynecology, and pediatrics residency program websites for number of DEI elements present. By identifying lacking DEI content, we hope to give residency programs that are seeking to increase diversity among applicants some direction for improving their websites.
    Methods: We reviewed all available residency program websites (1814) in the Fellowship and Residency Electronic Interactive Database (FREIDA) from August to December 2021. Each website was evaluated for the presence of 10 DEI elements chosen from previously published website reviews and informal applicant surveys. Some elements included the presence of resident and faculty photos/biographies, patient population descriptions, and dedicated DEI curricula. Program demographic information was collected, and summative statistics were performed.
    Results: The average number of DEI elements displayed per program ranged from 3.5 (internal medicine) to 4.9 (pediatrics). The most common elements were resident and faculty photographs/biographies. Internal medicine programs displayed significantly fewer elements than the other 3 specialties. This difference remained significant after controlling for program size, location, and type.
    Conclusions: This study highlights a lack of DEI elements available for residency program website visitors to review.
    MeSH term(s) Pregnancy ; Female ; Humans ; Child ; Internship and Residency ; Family Practice ; Diversity, Equity, Inclusion ; Obstetrics ; Internal Medicine
    Language English
    Publishing date 2023-06-14
    Publishing country United States
    Document type Review ; Journal Article
    ZDB-ID 2578612-X
    ISSN 1949-8357 ; 1949-8357
    ISSN (online) 1949-8357
    ISSN 1949-8357
    DOI 10.4300/JGME-D-22-00329.1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  3. Article ; Online: Formulary management of 2 new agents: lorcaserin and phentermine/topiramate for weight loss.

    Kelly, Elizabeth M / Tungol, Alexandra A / Wesolowicz, Laurie A

    Journal of managed care pharmacy : JMCP

    2013  Volume 19, Issue 8, Page(s) 642–654

    Abstract: Background: Obesity may lead to the development of multiple chronic disease states, including hypertension, dyslipidemia, and type 2 diabetes mellitus. Over a half billion adults worldwide are affected by obesity, and more than two-thirds of adults are ... ...

    Abstract Background: Obesity may lead to the development of multiple chronic disease states, including hypertension, dyslipidemia, and type 2 diabetes mellitus. Over a half billion adults worldwide are affected by obesity, and more than two-thirds of adults are either obese or overweight in the United States. Diet and exercise have been the mainstays of treatment in this population; however, once failed, noninvasive, long-term effective treatment modality is lacking, and medications may potentially fill the void. Lorcaserin and phentermine/topiramate were approved by the FDA in June 2012 and July 2012, respectively, as adjuncts to diet and exercise for chronic weight management of obese (body mass index [BMI] ≥ 30 kg/m2) or overweight (BMI ≥ 27 kg/m2) individuals with comorbidities.
    Objective: To review the phase 3 trials of lorcaserin and phentermine/topiramate and provide managed care considerations that may be taken into account as a result.
    Methods: A MEDLINE review was performed for articles published and available through September 17, 2012, using keywords "lorcaserin" or "phentermine/topiramate" with an emphasis on phase 3 trials. The literature search was limited to randomized controlled trials in humans published in the English language. Additional information on lorcaserin from its FDA review was obtained from the FDA website.
    Results: 5 pivotal phase 3 trials were identified: 3 for lorcaserin and 2 for phentermine/topiramate. Both agents demonstrated a statistically significant higher proportion of individuals who lost ≥ 5% of body weight, as well as higher mean weight loss when compared with placebo. Safety concerns for lorcaserin include cardiac valvulopathy and increased risk of psychiatric, cognitive, and serotonergic adverse effects. Teratogenicity and increased heart rate are major safety concerns regarding phentermine/topiramate.
    Conclusions: Health care decision makers have many factors to consider when developing strategies to fight obesity. Despite a great need for new therapies to treat obesity, medications used for weight loss have significant side-effect profiles and contraindications that may limit therapy. An appropriate utilization management strategy is needed.
    MeSH term(s) Adult ; Anti-Obesity Agents/adverse effects ; Anti-Obesity Agents/therapeutic use ; Appetite Depressants/adverse effects ; Appetite Depressants/therapeutic use ; Benzazepines/adverse effects ; Benzazepines/therapeutic use ; Body Weight/drug effects ; Clinical Trials, Phase III as Topic ; Female ; Fructose/adverse effects ; Fructose/analogs & derivatives ; Fructose/therapeutic use ; Humans ; Male ; Obesity/drug therapy ; Phentermine/adverse effects ; Phentermine/therapeutic use ; Randomized Controlled Trials as Topic ; Topiramate ; Weight Loss/drug effects
    Chemical Substances Anti-Obesity Agents ; Appetite Depressants ; Benzazepines ; Topiramate (0H73WJJ391) ; Fructose (30237-26-4) ; lorcaserin (637E494O0Z) ; Phentermine (C045TQL4WP)
    Language English
    Publishing date 2013-05-17
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2022394-8
    ISSN 1944-706X ; 1083-4087
    ISSN (online) 1944-706X
    ISSN 1083-4087
    DOI 10.18553/jmcp.2013.19.8.642
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 5450: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (2.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  4. Book ; Conference proceedings: The new and more open outlook for the mentally retarded;

    Kelly, Elizabeth M

    the proceedings. Ed. by Elizabeth M. Kelly

    1966  

    Event/congress Workshop on Mental Retardation (1965, CatholicUniversityofAmerica)
    MeSH term(s) Education of Intellectually Disabled
    Language English
    Size xviii, 122 p.
    Publisher Catholic University of America Press
    Publishing place Washington
    Document type Book ; Conference proceedings
    Database Catalogue of the US National Library of Medicine (NLM)

    More links

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

To top